10X Genomics, Inc. Reagents for the Critical Care Medicine Departments (CCMD)

Closed Pre-Solicitation Posted

Solicitation number
24-008747
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department (CCMD) intends to award a fixed-price contract to 10X Genomics, Inc. for various reagents to be used with the Chromium X equipment. The reagents are needed to support a research project examining immune mechanisms in controlling responses to Pneumocystis infection in immunocompromised and critically ill patients. The merits of the 10X Genomics technology have been validated, and the reagents are proprietary and required for use with the existing instrumentation. This acquisition will be conducted using simplified acquisition procedures under FAR Part 13, as the contracting officer has determined that 10X Genomics is the only reasonably available source.

This is a sole-source procurement with no set-aside designation. The contract will have a five-month base year. The products to be procured include Chromium Next GEM reagents, Chromium Next GEM chips, Library Construction Kit, Dual Index Kit, Chromium Single Cell, and other related reagents and supplies. The estimated value of the contract is not provided, and the quantity of goods to be procured is not specified.

Notice text

10X Genomics, Inc. Reagents for the Critical Care Medicine Departments (CCMD)

  • Product Service Code: 6550
  • NAICS Code: 325413
  • Place of Performance:

Bethesda, MD 20892

POTS: 24-008747

Description

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of Critical Care Medicine Department (CCMD) intends to award a fixed price contract with a five (5) month base year to 10X Genomics, Inc, Pleasanton, California 94588-3260 on a sole source basis to provide various reagents to use with the Chromium X equipment.

The Critical Care Medicine Department (CCMD) is currently working on a research project determining immune mechanisms in controlling responses to Pneumocystis infection. The project consists of immunocompromised and critically ill patients. Highly sensitive single-cell RNA-seq is a critical technology that will be performed in the Chromium X equipment. The merits of the technology have been validated through consistent studies. Proprietary 10X Genomics, Inc. reagents must be used with existing instrumentation.  There are no other known sources that can supply the various reagents.  Using any other reagents not compatible with the Chromium X equipment would potentially damage the equipment and cause erroneous testing results.  It is imperative to procure the 10X Genomics reagents to maintain consistency and continuity of the research project in support of patient care.  

Products

Chromium Next GEM reagents, Chromium Next GEM chips, Library Construction Kit, Dual Index Kit, Chromium Single Cell, and other reagents and supplies from 10 x genomics not limited to the above.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe, Contract Specialist, lowet2@mail.nih.gov by the due date May 26, 2024 and time marked in this notice.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
RNA sequencing and whole genome sequencing services Bethesda, Maryland 20892, United States · NAICS 32599 Office of Logisitics and Acquisition Operations No set-aside
Combined Synopsis Solicitation- Acquire Flow Cytom NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests. Seattle, Washington 98108, United States · NAICS 325413 Veterans Integrated Service Network 20 No set-aside
6550--Cepheid GeneXpert Testing Supplies Beckley Vamc Clarksburg Vamc Vamhcs Washington Vamc · NAICS 325413 Veterans Integrated Service Network 5 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors